Aurora Cannabis Inc. (NYSE: ACB) Q3 2021 earnings call dated May. 14, 2021
Corporate Participants:
Ananth Krishnan — Vice President, Corporate Development and Investor Relations
Miguel Martin — Chief Executive Officer
Glen Ibbott — Chief Financial Officer
Analysts:
Vivien Azer — Cowen and Company — Analyst
Pablo Zuanic — Cantor Fitzgerald — Analyst
Frederico Yokota Choucair Gomes — ATB Capital Markets — Analyst
Michael S. Lavery — Piper Sandler — Analyst
Heather Balsky — Bank of America Securities — Analyst
Matt McGinley — Needham — Analyst
Tamy Chen — BMO Capital Markets — Analyst
John Zamparo — CIBC Capital Markets — Analyst
John Chu — Desjardins Capital Markets — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Listen On
